<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>James Routley | Feed</title>
    <link
      rel="stylesheet"
      type="text/css"
      href="../styles.css"
      media="screen"
    />
  </head>
  <body>
    <a href="/index.html">Back</a>
    <a href="https://pubmed.ncbi.nlm.nih.gov/36054264/">Original</a>
    <h1>mRNA-LNP inhibits adaptive immune response, alters immune fitness inheritably</h1>
    
    <div id="readability-page-1" class="page"><div id="article-page" data-article-pmid="36054264">
    <div id="article-details">
      
        


<header id="heading">
  
    
      
  



  <p><span>
      
<span>PLoS Pathog</span><span>. </span><span>2022 Sep 2;18(9):e1010830.</span>

    </span>
  
  
    
      <span>
        doi: 10.1371/journal.ppat.1010830.
      </span>
    
    
      <span>
        Online ahead of print.
      </span>
    
    
    
  

</p>
  


<div>
  


  
    <div id="full-view-expanded-authors">
      
        
      

      

      

      

      

      
        <div>
          <h3>
            Affiliation
          </h3>
          <ul>
            
              <li data-affiliation-id="affiliation-1"><sup>1</sup> Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.</li>
            
          </ul>
        </div>
      

      

      
    </div>
  


</div>

  
    <ul id="full-view-identifiers">
      
        <li>
          <span>
  <span>
    
      PMID:
    
  </span>

  
    <a target="_blank" rel="noopener" ref="linksrc=article_id_link&amp;article_id=36054264&amp;id_type=PubMed" href="http://pubmed.ncbi.nlm.nih.gov/36054264/" data-ga-category="full_text" data-ga-action="PMID">
      36054264
    </a>
  

  
</span>

        </li>
      
        <li>
          <span>
  <span>
    
      DOI:
    
  </span>

  
    <a target="_blank" rel="noopener" ref="linksrc=article_id_link&amp;article_id=10.1371/journal.ppat.1010830&amp;id_type=DOI" href="https://doi.org/10.1371/journal.ppat.1010830" data-ga-category="full_text" data-ga-action="DOI">
      10.1371/journal.ppat.1010830
    </a>
  

  
</span>

        </li>
      
    </ul>
  



    
  
</header>

        



  <div id="abstract">
    
      <h2>
        Abstract
        
      </h2>
      
        
          
            <p>
      
      Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been administered to humans. However, we lack a comprehensive understanding of the immune effects of this platform. The mRNA-LNP-based SARS-CoV-2 vaccine is highly inflammatory, and its synthetic ionizable lipid component responsible for the induction of inflammation has a long in vivo half-life. Since chronic inflammation can lead to immune exhaustion and non-responsiveness, we sought to determine the effects of pre-exposure to the mRNA-LNP on adaptive immune responses and innate immune fitness. We found that pre-exposure to mRNA-LNPs or LNP alone led to long-term inhibition of the adaptive immune response, which could be overcome using standard adjuvants. On the other hand, we report that after pre-exposure to mRNA-LNPs, the resistance of mice to heterologous infections with influenza virus increased while resistance to Candida albicans decreased. The diminished resistance to Candida albicans correlated with a general decrease in blood neutrophil percentages. Interestingly, mice pre-exposed to the mRNA-LNP platform can pass down the acquired immune traits to their offspring, providing better protection against influenza. In summary, the mRNA-LNP vaccine platform induces long-term unexpected immunological changes affecting both adaptive immune responses and heterologous protection against infections. Thus, our studies highlight the need for more research to determine this platform&#39;s true impact on human health.
    </p>
          
        
      

      
    

    

    

  </div>


        
        



        
        

        

        

        

        

        



        



      
    </div>
  </div></div>
  </body>
</html>
